Skip to content
Home/Companies/MedTech/Amber Therapeutics
AT

Amber Therapeutics

MedTech·UK·Active·5yr hold

Amber Therapeutics is a MedTech company, headquartered in UK.

Entry
2021
Hold
5yr
Status
Active
Est. EV
–

Who owns Amber Therapeutics?

Amber Therapeutics is currently owned by Oxford Science Enterprises through Oxford Science Enterprises Balance Sheet (2015 vintage), since 2021.

Hand-verified · updated 2026-07-16

Oxford Science Enterprises
Investor
Oxford Science Enterprises
Oxford Science Enterprises Balance Sheet · 2015 · Balance Sheet

Key facts

HQUK
SectorMedTech
StatusActive

More from Oxford Science Enterprises Balance Sheet

Other portfolio companies in the same fund.

Allos
Active
AI/MLUK· 2026
Caudal Energy
Active
EnergyUK· 2026
Densix
Active
Deep TechUK· 2026
Marley Health
Active
HealthTechUK· 2026
Stateful Robotics
Active
Deep TechUK· 2026
Alethio Therapeutics
Active
BiotechUK· 2025

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Axomove
Active
Go CapitalFrance· 2026
Bioliberty
Active
Scottish National Investment BankUK· 2026
CertHub
Active
Cusp Capital PartnersGermany· 2026
Custom Surgical
Active
ZEISS VenturesGermany· 2026
DiappyMed
Active
Irdi Capital-InvestissementFrance· 2026
Hipp Technology Group
Active
Deutsche Beteiligungs AGGermany· 2026
Data refreshed weekly · Sourced from public filings